Obvious-Type Double Patenting and PTEs After Breckenridge Pharmaceutical and Ezra Ventures LLC Decisions
March 14, 2019
Webinar
Strafford Publications
As part of Strafford Publications' webinar series, Finnegan partners Tom Irving, Adriana Burgy, and Jill MacAlpine will discuss double patenting. The program will analyze recent court treatment; offer best practices to defeat double patenting rejections and avoid terminal disclaimers; and provide specific language to consider if a terminal disclaimer must be filed. For more information, or to register, please see Strafford Publications' website.
